Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
HCC1937
TNBC
Basal A
Carboplatin
DNA cross-linker
DNA cross-linker
10262.021
uM
37.6510
50.43530
-0.9519 -0.8597 3.4222 0.4481
0.9944
0.6806
HCC1937
TNBC
Basal A
Carboplatin
DNA cross-linker
DNA cross-linker
7834.075
uM
40.66670
90.07460
-0.6087 -0.6806 1.0804 0.3561
0.9982
2.0182
HCC1937
TNBC
Basal A
Cetuximab
EGFR
ErbB
7833.042
uM
inf
inf
0.8856 0.8856 0.0000 0.0972
0.0274
1.0332
HCC1937
TNBC
Basal A
Cetuximab
EGFR
ErbB
7834.018
uM
inf
inf
0.8939 0.8939 0.0000 0.0410
0.4149
1.8951
HCC1937
TNBC
Basal A
Cetuximab
EGFR
ErbB
7832.042
uM
0.57736
1.87360
0.4323 -1.0000 0.9333 0.0778
0.8653
1.2810
HCC1937
TNBC
Basal A
CGC-11047
Polyamine analogue
7834.018
uM
14.58470
764.7230
-0.4460 -1.0000 0.2775 0.5236
0.9101
1.8951
HCC1937
TNBC
Basal A
CGC-11047
Polyamine analogue
10262.034
uM
2.42290
59.75010
-0.9033 -1.0000 0.3428 0.7559
0.9172
0.6634
HCC1937
TNBC
Basal A
Cisplatin
DNA cross-linker
DNA cross-linker
7833.017
uM
inf
inf
0.2921 0.2921 0.0000 0.1679
0.5260
1.2975
HCC1937
TNBC
Basal A
Cisplatin
DNA cross-linker
DNA cross-linker
10262.021
uM
5.06270
8.92370
-0.9411 -0.8884 1.8018 0.4842
0.9909
0.6806
HCC1937
TNBC
Basal A
Cisplatin
DNA cross-linker
DNA cross-linker
7834.13
uM
3.49250
6.46710
-0.6646 -0.6160 1.3032 0.4666
0.9939
1.9535
HCC1937
TNBC
Basal A
Cisplatin
DNA cross-linker
DNA cross-linker
7832.017
uM
3.09750
4.99740
-0.8487 -0.8107 2.0147 0.5488
0.9987
1.3404
HCC1937
TNBC
Basal A
CPT-11
TOP1
TOP
10262.034
uM
6.33790
16.09640
-0.8558 -1.0000 1.1787 0.2986
0.9773
0.6634
HCC1937
TNBC
Basal A
CPT-11
TOP1
TOP
7833.007
uM
10.7270
30.9040
-0.0519 -0.5994 0.7447 0.1769
0.9924
1.2952
HCC1937
TNBC
Basal A
Dactolisib
PI3K
PI3K
11849.155
uM
inf
0.35385
0.5815 0.5264 5.0000 0.1889
0.6353
1.4975
HCC1937
TNBC
Basal A
Dichloroacetate
PDK
PDK
13115.176
uM
inf
0.22160
0.8209 0.8738 5.0000 0.0131
0.6538
0.8197
HCC1937
TNBC
Basal A
Disulfiram
Proteasome
Proteasome
13115.174
uM
0.08360
0.08711
-0.7883 -0.1139 4.9999 0.5498
0.7045
0.8122
HCC1937
TNBC
Basal A
Docetaxel
TUBB
TUBB
10262.002
uM
0.00534
0.00521
0.0885 0.0565 5.0000 0.5451
0.9835
0.6356
HCC1937
TNBC
Basal A
Doxorubicin
TOP2
TOP
7833.007
uM
inf
inf
-0.0795 -0.0795 0.0000 0.4727
0.4296
1.2952
HCC1937
TNBC
Basal A
Doxorubicin
TOP2
TOP
10262.034
uM
0.29470
0.74270
-0.8572 -0.8195 1.0498 0.6968
0.9915
0.6634
HCC1937
TNBC
Basal A
Epirubicin
TOP2
TOP
7833.017
uM
inf
inf
0.3101 0.3101 0.0000 0.2828
0.5559
1.2975
HCC1937
TNBC
Basal A
Epirubicin
TOP2
TOP
7832.017
uM
0.20024
0.46689
-0.9960 -0.7800 1.1103 0.8016
0.9816
1.3404
HCC1937
TNBC
Basal A
Erlotinib
EGFR
ErbB
7453.091
uM
61.32890
999.85560
0.4611 -0.7525 0.3290 0.1505
0.9376
1.5914
HCC1937
TNBC
Basal A
Etoposide
TOP2
TOP
7452.074
uM
4.55290
7.95810
-0.3493 -0.3867 1.0260 0.3818
0.9932
1.5162
HCC1937
TNBC
Basal A
Etoposide
TOP2
TOP
7453.074
uM
5.28690
8.98490
-0.3367 -0.3700 1.0444 0.3794
0.9958
1.5871
HCC1937
TNBC
Basal A
Everolimus
MTOR
MTOR
11849.156
uM
0.71938
10.34880
-0.8391 -1.0000 0.4120 0.4321
0.7829
1.0836